Newsroom

Categories: Healthcare, Medical Devices & Technology

Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director

January 26, 2026

Categories: Drug Discovery & Development, Clinical Research & Trials

Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to include Morocco and Egypt.

January 9, 2026

Categories: Healthcare, COVID-19, Clinical Research & Trials

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

December 4, 2025

Categories: Biotechnology, Microbiology & Infection Control, Corporate, Finance & Investor

Lonza to expand bioscience testing offering with the acquisition of Redberry

October 30, 2025

Categories: Biotechnology, Corporate, Finance & Investor, Clinical Diagnostics

EazeBio and UC Santa Cruz announce strategic partnership to advance instrument-free diagnostic platform

October 29, 2025

Categories: Biotechnology, Drug Discovery & Development

Alithea Genomics introduces MERCURIUS™ Spheroid DRUG-seq: extraction-free, RNA-seq for 3D drug screening and toxicology

October 9, 2025

Categories: Biomanufacturing, Clinical Research & Trials

Lonza expands its TheraPEAK® product portfolio with the addition of AmpliCell® Cytokine range and TheraPEAK® 293-GT® Medium

October 6, 2025

Categories: Biomanufacturing, General Laboratory

PromoCell enters the GMP field with custom cell culture media services for cell-based  therapy and regenerative medicine

September 30, 2025

Categories: Drug Discovery & Development, Pharma

Takara Bio Europe launches Cellartis® MSC EV Wonder™, a defined, xeno-free medium for high-yield EV production

September 24, 2025